Predicting local recurrence using PAM50 in postmenopausal endocrine responsive breast cancer patients.
Florian Fitzal
Honoraria - AstraZeneca
Martin Filipits
No relevant relationships to disclose
Christian Fesl
No relevant relationships to disclose
Margaretha Rudas
No relevant relationships to disclose
Peter Christian Dubsky
Research Funding - Agendia; Cividon
Rupert Bartsch
No relevant relationships to disclose
Peter Regitnig
No relevant relationships to disclose
Thomas Bauernhofer
No relevant relationships to disclose
Richard Greil
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Gerhard Leitner
No relevant relationships to disclose
Michael Knauer
Research Funding - Agendia
Michael Hubalek
Honoraria - AstraZeneca
Michael A. Fridrik
No relevant relationships to disclose
Walter Herz
No relevant relationships to disclose
Otto Dietze
No relevant relationships to disclose
John W Cowens
Employment or Leadership Position - NanoString Technologies
Stock Ownership - NanoString Technologies
Sean Ferree
Employment or Leadership Position - NanoString Technologies
Stock Ownership - NanoString Technologies
Torsten O. Nielsen
Consultant or Advisory Role - NanoString Technologies
Michael Gnant
Consultant or Advisory Role - Accelsiors; AstraZeneca; Novartis
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; NanoString Technologies; Novartis; Roche
Research Funding - GlaxoSmithKline; Pfizer; Roche; Sanofi ; Smith Medical